Skip to content

Sichenzia Ross Ference Carmel LLP Represents Dominari Securities and Madison Global Partners in $2.1 Million Registered Direct Offering of authID

Sichenzia Ross Ference Carmel LLP Represents WallachBeth Capital in $3.25 Million Public Offering of bioAffinity Technologies

Sichenzia Ross Ference Carmel LLP Represents Pineapple Financial Inc. in $1.5 Million Public Offering

Sichenzia Ross Ference Carmel LLP Represents Dominari Securities in $40 Million Confidentially Marketed Public Offering of Unusual Machines, Inc. Common Stock

Sichenzia Ross Ference Carmel LLP Named Most Active Issuer Counsel Among Securities Law Firms in PlacementTracker’s PIPE and Private Placement Markets League Tables for Q1 2025

Sichenzia Ross Ference Carmel LLP Represents Lexaria Bioscience Corp. in $2 Million Registered Direct Offering

Sichenzia Ross Ference Carmel LLP Represents BriaCell Therapeutics in $13.8 Million Public Offering

Sichenzia Ross Ference Carmel LLP Represents D. Boral Capital in $6.4 Million Initial Public Offering of Phoenix Asia Holdings

Sichenzia Ross Ference Carmel LLP Represents Safe & Green Holdings Corp. in a $8 Million Private Placement

Sichenzia Ross Ference Carmel LLP Represents FatPipe, Inc. in Closing of $4 Million Initial Public Offering

Sichenzia Ross Ference Carmel Names Matilde Tysz as Chief Strategy Officer

Sichenzia Ross Ference Carmel LLP Represents ThinkEquity in $6.4 Million Private Placement of Perfect Moment Ltd.

Sichenzia Ross Ference Carmel LLP Represents Sunshine Biopharma Inc. in $2.46 Million Registered Direct Offering

Q1 2025 Recap: Sichenzia Ross Ference Carmel Closes 45 Capital Markets Transactions Valued at Over $500 Million; Adds Managing Partner; and Continues its Ascent Among Securities Law Firm Ranks

Sichenzia Ross Ference Carmel LLP Represents MKDWELL Tech Inc. in $10 Million Private Placement Offering

Sichenzia Ross Ference Carmel LLP Represents Soulpower Acquisition Corporation in $220 Million Upsized Initial Public Offering

Sichenzia Ross Ference Carmel LLP Represents Calidi Biotherapeutics, Inc. in $3.9 Million Registered Direct Offering and Concurrent Private Placement

Founding Partner Gregory Sichenzia Featured in Law360 Article About Nasdaq’s Tighter IPO Rules

Sichenzia Ross Ference Carmel LLP Represents Dominari Securities in $8.15 Million Registered Direct Offering of authID

Sichenzia Ross Ference Carmel LLP Represents RBW Capital Partners in the Direct Listing of NeOnc Technologies Holdings to Nasdaq

Sichenzia Ross Ference Carmel LLP Represents an Institutional Investor in the $1 Million Registered Direct Offering of IntChains Group